These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 38521429

  • 1. Orcinol gentiobioside inhibits RANKL-induced osteoclastogenesis by promoting apoptosis and suppressing autophagy via the JNK1 signaling.
    Lian C, Gong W, Zhao X, Sun P, Hu S, Zhou G, Zhang Q, Qin L.
    J Ethnopharmacol; 2024 Jun 28; 328():118060. PubMed ID: 38521429
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.
    Gong W, Liu M, Zhang Q, Zhang Q, Wang Y, Zhao Q, Xiang L, Zheng C, Zhang Q, Qin L.
    Oxid Med Cell Longev; 2022 Jun 28; 2022():5410377. PubMed ID: 35585885
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.
    Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR, Kingery WS.
    Bone; 2010 May 28; 46(5):1369-79. PubMed ID: 19962460
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Zanthoxylum bungeanum seed oil inhibits RANKL-induced osteoclastogenesis by suppressing ERK/c-JUN/NFATc1 pathway and regulating cell cycle arrest in RAW264.7 cells.
    He F, Luo S, Liu S, Wan S, Li J, Chen J, Zuo H, Pei X.
    J Ethnopharmacol; 2022 May 10; 289():115094. PubMed ID: 35149133
    [Abstract] [Full Text] [Related]

  • 8. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL, Chen CL, Lai CC, Lee CC, Chang DM.
    Phytomedicine; 2020 Apr 10; 69():153195. PubMed ID: 32200293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L, Yang M, Shrestha SK, Kim H, Gerwick WH, Soh Y.
    Int J Mol Sci; 2021 Feb 25; 22(5):. PubMed ID: 33669069
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC.
    Med Sci Monit; 2018 Apr 26; 24():2569-2577. PubMed ID: 29698379
    [Abstract] [Full Text] [Related]

  • 13. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X, Xiao Y, Chen Z, Ma J, Qiu W, Zhang K, Xu F, Dang K, Qian A.
    Mol Cell Endocrinol; 2019 Aug 20; 494():110494. PubMed ID: 31260729
    [Abstract] [Full Text] [Related]

  • 14. Cerium Oxide Nanoparticles Regulate Osteoclast Differentiation Bidirectionally by Modulating the Cellular Production of Reactive Oxygen Species.
    Yuan K, Mei J, Shao D, Zhou F, Qiao H, Liang Y, Li K, Tang T.
    Int J Nanomedicine; 2020 Aug 20; 15():6355-6372. PubMed ID: 32922006
    [Abstract] [Full Text] [Related]

  • 15. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
    van Heerden B, Kasonga A, Kruger MC, Coetzee M.
    Nutrients; 2017 Apr 28; 9(5):. PubMed ID: 28452958
    [Abstract] [Full Text] [Related]

  • 16. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT, Dat NT, Dang NH, Van Cuong P, Lee S, Hwangbo C, Van Minh C, Lee JH.
    Phytomedicine; 2019 Mar 01; 55():1-8. PubMed ID: 30668419
    [Abstract] [Full Text] [Related]

  • 17. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
    Ke D, Zhu Y, Zheng W, Fu X, Chen J, Han J.
    Biochimie; 2019 Dec 01; 167():217-227. PubMed ID: 31654668
    [Abstract] [Full Text] [Related]

  • 18. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH, Darvin P, Kang DY, Sp N, Byun HJ, Lee CH, Lee HK, Yang YM.
    PLoS One; 2016 Dec 01; 11(7):e0159891. PubMed ID: 27447722
    [Abstract] [Full Text] [Related]

  • 19. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.
    Jiang C, Wang Y, Zhang M, Xu J.
    Mol Biol Rep; 2022 Oct 01; 49(10):9217-9229. PubMed ID: 35881223
    [Abstract] [Full Text] [Related]

  • 20. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
    Zhang G, Wang Y, Tang G, Ma Y.
    BMC Complement Altern Med; 2019 Oct 15; 19(1):269. PubMed ID: 31615565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.